Lv41
418 积分 2024-08-26 加入
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update
57分钟前
待确认
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
1小时前
已完结
Mechanisms of drug resistance in HCC
5小时前
已完结
Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
9天前
已完结
Type I MET inhibitors cooperate with PD-1 blockade to promote rejection of hepatocellular carcinoma
9天前
已完结
EGFR Inhibition Overcomes Resistance to FGFR4 Inhibition and Potentiates FGFR4 Inhibitor Therapy in Hepatocellular Carcinoma
9天前
已完结
Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies
9天前
已完结
mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment
9天前
已完结
FBXO22 promotes HCC angiogenesis and metastasis via RPS5/AKT/HIF-1α/VEGF-A signaling axis
9天前
已完结
Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion
11天前
已完结
皖公网安备34019202002308
